加载中…
加载中…
Process architecture
The baculovirus–insect system handles challenging ECDs, phosphorylated substrates and multisubunit complexes with flexible titration windows.
Membrane ECDs, particulate antigen ideas, phosphorylated substrates, and payloads that mammalian hosts struggle to secrete cleanly.
Industrial sequence—swap copy with your internal GXP narrative when ready.
Landing pages that pair host trade-offs with concrete catalogue or application cues — keep exploratory science on public routes before RFQ escalation.
Summaries from IA platform hubs — current host highlighted in gold.
| Platform | QC highlights | Timeline cues | Open |
|---|---|---|---|
| Mammalian · HEK293 | Routine SDS-PAGE, SEC-HPLC and endotoxin data; BLI/Octet-style binding assays on demand, plus project-specific COAs. | Transient timelines depend on sequence complexity and scale; schedules are quoted after scientific and PM review. | Open |
| Mammalian · CHO | QC panels may include purity, glycan profiling, potency/binding assays, residuals and microbial attributes per program. | Stable cell line generation and upstream development vary by modality; milestones are mapped once the scope-of-work locks. | Open |
| Prokaryotic · E. coli | Solubility tiers drive lysis, refold or secretion strategies; purity and contaminant profiling follow the bespoke route. | Bacterial runs iterate quickly once constructs behave; timelines stretch when refolding optimization is needed. | Open |
| Baculovirus / insect cells | Key readouts span titer, purity, baculovirus/HCP residuals, plus binding or particle-integrity assays when justified. | BAC-to-titer timelines depend on vector optimization iterations; checkpoints are clarified during intake. | Viewing |
Slug PDP samples where Source/wording maps to this host family; sibling platform hubs clarify modality trade-offs.
Other hosts that overlap on curated targets or application hubs—compare glyco, titer, and workflow trade-offs across Puweituo Bio modalities.
Cross-links for the research navigation hub (themes often produced on this platform).
Key readouts span titer, purity, baculovirus/HCP residuals, plus binding or particle-integrity assays when justified.
BAC-to-titer timelines depend on vector optimization iterations; checkpoints are clarified during intake.
Contrast titers, glycosylation depth, turnaround and cost envelopes with sibling hosts directly on Puweituo Bio—technical sales can cite program-specific benchmarking data on request.
Navigate from bench-scale catalogs to turnkey expression programs.